Our Facilities
WuXi AppTec's primary China-based facilities include a 782,000-square-foot R&D center, and a 22,000-square-foot cGMP-quality formulation pilot plant in Shanghai Waigaoqiao Free Trade Zone; a 293,000-square-foot cGMP-quality process development and manufacturing plant in the Jinshan area of Shanghai; a 253,000-square-foot R&D center in Tianjin; and a 314,000-square-foot toxicology center in Suzhou.
We are well-positioned to capitalize on the advantages of conducting R&D services both in China and in the U.S., while emphasizing quality, responsiveness, protection of customer intellectual property, and reliability.
Our U.S.-based facilities are all FDA-registered, including an 82,000-square-foot R&D, testing and manufacturing facility in St. Paul, Minnesota; a 51,000-square-foot testing facility in Atlanta, Georgia; and a 75,000-square-foot R&D, testing and manufacturing facility in Philadelphia, Pennsylvania.
Click here for contact information for WuXi AppTec’s facilities.